Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urologic Neoplasms × Albumins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Urologic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Hematologic Diseases 1 Colorectal Neoplasms 1

Interventions

Gemcitabine 8 pembrolizumab 6 atezolizumab 4 Trastuzumab 4 Cisplatin 4 Carboplatin 4 enfortumab vedotin 3 Sunitinib 3 Pemetrexed 3 Mitomycin 3 dodecyl maltoside 2 cabozantinib 2 Water 2 Sugammadex 2 Standard of Care 2 Saline Solution 2 Paclitaxel 2 Nivolumab 2 Neostigmine 2 Docetaxel 2 Cetuximab 2 Bevacizumab 2 zidovudine 5'-monophosphate-mannose-albumin conjugate 1 vinflunine 1 valrubicin 1 tucatinib 1 tislelizumab 1 testosterone 17 beta-cypionate 1 temsirolimus 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05726136 2024-03-18

FC-VE

University Hospital, Linkoeping

Phase 4 Unknown

GastrointestinalGenitourinary

Neoplasms, Urologic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡